Evidence map›Paper›PMID 36388657›Full record

ArticleJournal of gastrointestinal oncology2022

Progression of the tumor in a patient with a gastrointestinal stromal tumor with the

Zhaojie An, Ming Tan, Yuxiang Xia, Yong Li, Liqiao Fan, Qun Zhao, Zhidong Zhang, Bibo Tan, Yu Liu, Zhixue Ma and 2 more

Open access · diamondAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of gastrointestinal oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.3field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Zhaojie An *Department of General Surgery, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
Ming Tan *Department of General Surgery, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
Yuxiang Xia *Department of General Surgery, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
Yong LiDepartment of General Surgery, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
Liqiao FanDepartment of General Surgery, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
Qun ZhaoDepartment of General Surgery, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
Zhidong ZhangDepartment of General Surgery, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
Bibo TanDepartment of General Surgery, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
Yu LiuDepartment of General Surgery, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
Zhixue MaDepartment of General Surgery, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
Dong WangDepartment of General Surgery, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
Xuefeng ZhaoDepartment of General Surgery, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
Fourth Hospital of Hebei Medical University · CNHebei Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Targeted therapy with tyrosine kinase inhibitors (TKIs) benefits most patients with stromal tumors; however, the effects of TKIs in patients with rare cases of gastrointestinal stromal tumors (GISTs) with platelet-derived growth factor receptor alpha ( Case Description: We report the case of a patient (42-year-old female) with a Conclusions: This case showed that patients with

Indexed as

Case reportgastrointestinal stromal tumor (GIST)PDGFRA exon 12ripretinibtyrosine kinase inhibitor (TKI)

Identifiers

PMID36388657
PMCPMC9660055
OpenAlexW4308109659

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.